The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy.
Publication
, Journal Article
Mahaffey, KW; Becker, RC
Published in: Circulation
November 2006
Duke Scholars
Published In
Circulation
DOI
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 2006
Volume
114
Issue
22
Start / End Page
2313 / 2316
Related Subject Headings
- Thiophenes
- Rivaroxaban
- Postoperative Period
- Morpholines
- Humans
- Factor Xa
- Double-Blind Method
- Cardiovascular System & Hematology
- Arthroplasty, Replacement, Hip
- Anticoagulants
Citation
APA
Chicago
ICMJE
MLA
NLM
Mahaffey, K. W., & Becker, R. C. (2006). The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy. Circulation, 114(22), 2313–2316. https://doi.org/10.1161/circulationaha.106.664169
Mahaffey, Kenneth W., and Richard C. Becker. “The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy.” Circulation 114, no. 22 (November 2006): 2313–16. https://doi.org/10.1161/circulationaha.106.664169.
Mahaffey KW, Becker RC. The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy. Circulation. 2006 Nov;114(22):2313–6.
Mahaffey, Kenneth W., and Richard C. Becker. “The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy.” Circulation, vol. 114, no. 22, Nov. 2006, pp. 2313–16. Epmc, doi:10.1161/circulationaha.106.664169.
Mahaffey KW, Becker RC. The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy. Circulation. 2006 Nov;114(22):2313–2316.
Published In
Circulation
DOI
EISSN
1524-4539
ISSN
0009-7322
Publication Date
November 2006
Volume
114
Issue
22
Start / End Page
2313 / 2316
Related Subject Headings
- Thiophenes
- Rivaroxaban
- Postoperative Period
- Morpholines
- Humans
- Factor Xa
- Double-Blind Method
- Cardiovascular System & Hematology
- Arthroplasty, Replacement, Hip
- Anticoagulants